The invention provides compositions and methods for utilizing oligosaccharides, such as isolated human milk oligosaccharides, to attenuate a respiratory pathogen infection and/or to promote recovery from a respiratory pathogen infection in the respiratory system and/or the GI tract of a subject.

The present invention is a system and method for performing freeze drying of small quantities of a liquid for personal use, wherein a liquid material is disposed within a single-use container, the container is then coupled to a small-scale freeze-drying unit which extracts liquid from the material in the container using a freeze-drying process, and the freeze-dried material is then left in the container and the container is stored until rehydration. The container may be a specialized single-use container that may be used to rehydrate the liquid and then fitted with a delivery device to feed an infant or child.

An apparatus and method for organizing breast milk storage bags, comprising a refrigerated enclosure, a vertical carousel automated conveyor having a plurality of racks rotating around it vertical axis with such racks partitioned in a plurality of compartments wherein the breast milk storage bags are placed, a main door that allows access to the whole arrangement and a secondary door that allows easy access to one rack for retrieving or storing breast milk storage bags, such secondary door includes a load sensor and a plurality of light sources that indicates in which slot the desired bag is located. The apparatus further includes a control panel with a User Interface and employs an algorithm that selects the breast milk storage bags according to the desired ounces sorting them by nearest expiration date and keeping track of the breast milk inventory database which is able to be accessed through a mobile app.

The present disclosure provides a human milk fortifier product composition with, a protein component in the milk fortifier in an amount ranging from 6 wt/wt % to 35 wt/wt % on solids basis; a fat component in the in the milk fortifier in an amount ranging from 0.1 wt/wt % to 36 wt/wt % on solids basis; a carbohydrate in the milk fortifier selected from the group of Lactose and Oligosaccharides present in the in an amount from 25 wt/wt % to 75 wt/wt % on solids basis; small molecules consisting of Oligosaccharides in the human milk fortified by the said fortifier is at least 25% more than the human milk alone. The majority of small molecules consisting of Vitamin A, Vitamin D, Vitamin E, LCPUFA, Epidermal growth factor and many others are retained in the fortifier product.

Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for improving airway defense mechanisms.

The invention provides compositions and methods for utilizing oligosaccharides, such as isolated human milk oligosaccharides, to attenuate a respiratory pathogen infection and/or to promote recovery from a respiratory pathogen infection in the respiratory system and/or the GI tract of a subject.

The present invention provides a novel process for preparing fortified milk compositions from whole mammalian milk. The process of the present invention generally involves converting dried mammalian milk into a fats-enriched fraction, a protein-enriched fraction, and a carbohydrate-enriched fraction. The process comprises treating the dried milk with a fats extracting agent to provide a fats-enriched fraction, and a residual fraction comprising proteins and carbohydrates; separating said fats-enriched fraction from the residual fraction; and removing the fats extracting agent from the separated fats-enriched fraction to produce a dry fraction of oily, fats-enriched material and a fraction enriched in proteins and carbohydrates.

Provided herein are cultured milk products for use as nutritional supplements. Also provided are live cell constructs for producing the cultured milk products and bioreactors for producing the cultured milk products. Secretory IgA compositions and methods of use are also provided.

An apparatus and method for organizing breast milk storage bags, comprising a refrigerated enclosure, a vertical carousel automated conveyor having a plurality of racks rotating around it vertical axis with such racks partitioned in a plurality of compartments wherein the breast milk storage bags are placed, a main door that allows access to the whole arrangement and a secondary door that allows easy access to one rack for retrieving or storing breast milk storage bags, such secondary door includes a load sensor and a plurality of light sources that indicates in which slot the desired bag is located. The apparatus further includes a control panel with a User Interface and employs an algorithm that selects the breast milk storage bags according to the desired ounces sorting them by nearest expiration date and keeping track of the breast milk inventory database which is able to be accessed through a mobile app.

The present invention relates to a method for treating raw human milk to produce treated human milk having undetectable levels of bacteria. The milk is skimmed to produce skim human milk then subjected to microfiltration to yield a filtrate which has undetectable levels of bacteria, including Bacillus cereus. The resultant human milk can be further processed, used and/or sold.